User profiles for Bruno Crestani
 | Bruno Crestaniuniversité paris diderot Verified email at bch.aphp.fr Cited by 34721 |
An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …
…, CR Cordeiro, V Cottin, B Crestani… - American journal of …, 2013 - atsjournals.org
Background: In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS)
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline
…, I Buendia-Roldan, F Caro, B Crestani… - American Journal of …, 2022 - atsjournals.org
Background: This American Thoracic Society, European Respiratory Society, Japanese
Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior …
Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior …
Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
…, S Marchand-Adam, B Crestani… - American journal of …, 2010 - atsjournals.org
Rationale: Pulmonary fibrosis is a devastating as yet untreatable disease. We previously
investigated the endogenous mediators released on lung injury and showed that uric acid is a …
investigated the endogenous mediators released on lung injury and showed that uric acid is a …
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …
…, A Devaraj, L Richeldi, T Moua, B Crestani… - The lancet Respiratory …, 2020 - thelancet.com
Background The INBUILD trial investigated the efficacy and safety of nintedanib versus
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …
[HTML][HTML] MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
We read with great interest the series of cases reported by Mo et al. [1], describing pulmonary
function after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …
function after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast …
N Amara, D Goven, F Prost, R Muloway, B Crestani… - Thorax, 2010 - thorax.bmj.com
Background Persistence of myofibroblasts is believed to contribute to the development of
fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor β1 (TGFβ1) …
fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor β1 (TGFβ1) …
[HTML][HTML] European Respiratory Society statement on long COVID follow-up
…, AM Russell, C Andrejak, B Crestani… - European …, 2022 - Eur Respiratory Soc
Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death
M Wislez, N Rabbe, J Marchal, B Milleron, B Crestani… - Cancer research, 2003 - AACR
Increased numbers of tumor-infiltrating neutrophils are linked to poorer outcome in patients
with adenocarcinoma of the bronchioloalveolar carcinoma (BAC) subtype. Hepatocyte …
with adenocarcinoma of the bronchioloalveolar carcinoma (BAC) subtype. Hepatocyte …
Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.
…, A Flahault, C Philippe, B Crestani… - The American journal …, 1998 - ncbi.nlm.nih.gov
Tumor infiltrate, predominantly constituted by lymphocytes, may represent an important
prognostic factor in bronchioloalveolar carcinoma (BAC), in addition to tumor extension and …
prognostic factor in bronchioloalveolar carcinoma (BAC), in addition to tumor extension and …